News Archive | Page 13 of 23 | Lexaria Bioscience Corp.

News

Lexaria Receives US$737,500 from Exercise of Warrants

Kelowna, BC / December 2, 2016 / Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) announces it has received US$737,500 from the early exercise warrant incentive program announced on October 27,…

Lexaria Announces Price Cuts on ViPovaTM Tea Products.

Kelowna, BC / November 15, 2016 / Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) announces dramatic price cuts on all ViPovaTM tea products, just in time for the…

Lexaria Engages Consultants and Issues Options

Kelowna, BC / October 11, 2016 / Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) has retained Mackie Research Capital Corp. to provide market maintenance services for the company…

Lexaria Appoints New Auditors

Kelowna, BC / October 6, 2016 / Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) announces it has appointed Davidson and Company, LLP, Chartered Professional Accountants, as its new…

Lexaria Amends Financing Notice

Kelowna, BC / September 2, 2016 / Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) announces that due to a clerical error it is re-issuing its press release of…

Lexaria Closes Final Tranche of Fully Subscribed Financing

Kelowna, BC / August 31, 2016 / Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) announces it has closed the final tranche of the private placement equity financing announced…